Clinical Trial Update: A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating aticaprant as an adjunctive therapy for adults with major depressive disorder and moderate-to-severe anhedonia; the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Aticaprant (Aticaprant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major, Anhedonia | Phase 3 | Status: COMPLETED | Results posted: 2025-11-06